Indeed, there are quite a few inherent advantages in using WT1 as a target tumor antigen, namely: abundant expression in a wide variety of neoplasms, but with a very selective expression in mature physiological tissues and a significant difference in expression levels between healthy and neoplastic tissues [95]. The gene discussed is WT1; the disease is neoplasm.